A research collaboration offering precision CRISPR gene editing expertise for vegetable crops. Leveraging proven tissue culture protocols and novel in vivo screening methods, the team delivers transgene-free gene knockouts and chromosomal inversions. Ideal for partners seeking advanced crop improvement solutions without foreign DNA.
This offering provides access to a specialized research capability for precision gene editing in vegetable crops. The team combines deep expertise in tissue culture and CRISPR technology to deliver transgene-free gene edits, including targeted knockouts and chromosomal inversions. By optimizing CRISPR components and tissue culture protocols tailored to specific vegetable species, the group enables partners to achieve heritable genetic improvements without retaining foreign DNA in the final product. This approach addresses a key market and regulatory demand for clean gene-edited crops.
Core capabilities:
Track record:
The underlying gene editing and tissue culture methodologies have been validated in cereals and horticultural species, with editing efficiency improvements demonstrated in sorghum. The current phase focuses on adapting and validating these toolkits specifically for the target vegetable crop, including optimization of CRISPR component expression, guide RNA design, and tissue culture media. Once the toolkits are established in the candidate vegetable, the team will deploy them to create heritable gene knockouts and inversions, followed by rapid segregation of the CRISPR machinery in the next generation using speed breeding. The capability is positioned for pilot-scale validation and collaborative refinement with industry partners.
The University of Queensland is a large, multi-campus public research university in Brisbane with a comprehensive academic and research profile. Industry partners engage through hospital-embedded laboratories and clinical sites, pilot testbeds, and field campuses across Queensland that enable prototyping, trials, and validation in real-world settings. Co-location with major health precincts and proximity to Brisbane’s innovation districts make collaboration and talent access straightforward, while on-campus incubation and professional education support workforce upskilling. Research is supported by competitive national funding from the Australian Research Council and the National Health and Medical Research Council, alongside state and industry investment. A dedicated technology transfer office and commercialization company manage IP, licensing, sponsored research agreements, and spin-out formation.